INS and Insulin resistance: As insulin resistance progresses, VAT becomes less responsive to insulin's antilipolytic effects, further increasing the release of FFA and glycerol, ultimately perpetuating hepatic lipid overload and progressive insulin resistance (Nielsen and Jensen 2024).